AstraZeneca Pharma India net profit down 45 percent to Rs 10.24 crore in Q1
New Delhi: Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarter.The company had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.Revenue from operations stood at Rs 175.40 crore for the quarter under...
New Delhi: Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarter.
The company had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.
Revenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago, it added.
Read also: AstraZeneca Saphnelo gets USFDA nod for treating Systemic Lupus Erythematosus
The company's board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22, the filing said.
Read also: AstraZeneca India, BHU conduct cancer screening camp for women in Varanasi
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd